FGFR4 is a Prognostic Marker and Therapeutic Target for Ova...
FGFR4 is a Prognostic Marker and Therapeutic Target for Ovarian Cancer
In the journal Clinical Cancer Research, a group of researchers, including current and past OCRF grantees Anil Sood and Gabriel Lopez-Berestein, evaluated the prognostic value of fibroblast growth factor receptor 4 (FGFR4) protein expression in patients with advanced-stage, high-grade serous ovarian cancer. They found that FGFR4 is a prognostic marker for the disease. Furthermore, silencing FGFR4 significantly … Continued